No-Spa (Drotaverine Hydrochloride)

Drotaverine Hydrochloride, the active ingredient in No‑Spa, is an antispasmodic presented as an oral tablet for oral use. It relaxes smooth muscle and is employed to relieve abdominal, biliary, renal and menstrual cramp‑related spasms in adult patients. It is commonly prescribed in the European market for smooth‑muscle spasm management.

GNH USA supplies No‑Spa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Drotaverine Hydrochloride acts on smooth‑muscle spasm disorders across several organ systems. - Abdominal and gastrointestinal spasm: Relieves pain by relaxing smooth muscle in the GI tract. - Biliary colic: Reduces biliary duct spasms, easing discomfort during gallstone episodes. - Renal colic: Alleviates ureteral smooth‑muscle contraction associated with kidney stones. - Menstrual cramps (dysmenorrhea): Decreases uterine muscle tone to lessen menstrual pain.

Drotaverine Hydrochloride may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness. - Nausea or mild gastrointestinal upset. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Hypotension: significant drop in blood pressure. - Allergic reactions: rash, pruritus, or urticaria. - Cardiac arrhythmias: rare cases of irregular heartbeat. - Hepatic dysfunction: elevated liver enzymes in isolated reports.

Before using Drotaverine Hydrochloride, consider the following safety measures. - Cardiovascular disease: monitor blood pressure and heart rate. - Liver impairment: use with caution; assess hepatic function. - Renal impairment: adjust use based on renal function. - Concomitant antihypertensives: observe for additive blood‑pressure lowering effects. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Drotaverine Hydrochloride can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP450 inhibitors: may increase plasma levels of drotaverine. - Antihypertensive agents: risk of excessive hypotension.

Moderate Interactions (Monitor Closely): - Other antispasmodics: additive smooth‑muscle relaxation. - Diuretics: monitor electrolyte balance. - Anticholinergic drugs: potential for enhanced dry‑mouth or constipation.